Insider Trading Alert - Krispy Kreme Doughnuts And 2 Others Traded By Insiders

Yesterday, June 28, 2013, 151 U.S. common stocks issued filings of shares being bought or sold by insiders. The transactions ranged in value from $599.84 to $135,048,585.84.

Highlighted Stocks Traded by Insiders:

Krispy Kreme Doughnuts (KKD) - FREE Research Report

MARSCH DARRYL R. who is SVP & General Counsel at KRISPY KREME bought 79,000 shares at $6.81 per share for a total value of $523,999.00 on June 24, 2013. Following this transaction, the SVP & General Counsel owned 250,409 shares meaning that the stake was boosted by 35.05% with the 79,000 share acquisition.

The shares most recently traded at $17.50, down $0.01, or 0.06% since the insider transaction.

The average volume for Krispy Kreme Doughnuts has been 1.4 million shares per day over the past 30 days. Krispy Kreme Doughnuts has a market cap of $1.2 billion and is part of the services sector and leisure industry. Shares are up 86.67% year to date as of the close of trading on Thursday.

Krispy Kreme Doughnuts, Inc., together with its subsidiaries, operates as a branded retailer and wholesaler of doughnuts, beverages, and treats and packaged sweets worldwide. It owns and franchises Krispy Kreme stores. The company has a P/E ratio of 47.9. Currently there are 3 analysts that rate Krispy Kreme Doughnuts a buy, no analysts rate it a sell, and 3 rate it a hold.

Exclusive Offer: Get the latest Stock Analysis on KKD - FREE

TheStreet Quant Ratings rates Krispy Kreme Doughnuts as a buy. The company's strengths can be seen in multiple areas, such as its revenue growth, largely solid financial position with reasonable debt levels by most measures, good cash flow from operations, increase in net income and solid stock price performance. We feel these strengths outweigh the fact that the company has had somewhat disappointing return on equity. Get the full Krispy Kreme Doughnuts Ratings Report from TheStreet Quant Ratings now.

STOCKS TO BUY: TheStreet Quant Ratings has identified a handful of stocks that can potentially TRIPLE in the next 12-months. Learn more.

Opko Health (OPK) - FREE Research Report

FROST PHILLIP MD ET AL who is CEO & Chairman at OPKO HEALTH INC bought 15.5 million shares at $5.93 per share for a total value of $138,331.80 on June 25, 2013. Following this transaction, the CEO & Chairman owned 775.1 million shares meaning that the stake was boosted by 2.04% with the 15.5 million share acquisition.

The shares most recently traded at $7.14, down $0.02, or 0.28% since the insider transaction. Historical insider transactions for Opko Health go as follows:

  • 12-Week # shares bought: 4,300
  • 24-Week # shares bought: 9,300

The average volume for Opko Health has been 1.6 million shares per day over the past 30 days. Opko Health has a market cap of $2.4 billion and is part of the health care sector and health services industry. Shares are up 48.86% year to date as of the close of trading on Thursday.

Opko Health, Inc., a pharmaceutical and diagnostics company, engages in the discovery, development, and commercialization of novel and proprietary technologies. It operates in two segments, Pharmaceuticals and Diagnostics. Currently there are 3 analysts that rate Opko Health a buy, no analysts rate it a sell, and none rate it a hold.

Exclusive Offer: Get the latest Stock Analysis on OPK - FREE

TheStreet Quant Ratings rates Opko Health as a hold. The company's strengths can be seen in multiple areas, such as its robust revenue growth, solid stock price performance and expanding profit margins. However, as a counter to these strengths, we also find weaknesses including feeble growth in the company's earnings per share, deteriorating net income and disappointing return on equity. Get the full Opko Health Ratings Report from TheStreet Quant Ratings now.

STOCKS TO BUY: TheStreet Quant Ratings has identified a handful of stocks that can potentially TRIPLE in the next 12-months. Learn more.

Royal Gold (RGLD) - FREE Research Report

JENSEN TONY A who is President and CEO at ROYAL GOLD INC bought 2,000 shares at $39.69 per share for a total value of $79,380.00 on June 26, 2013. Following this transaction, the President and CEO owned 194,414 shares meaning that the stake was boosted by 1.04% with the 2,000 share acquisition.

STUCKERT JAMES W who is Director at ROYAL GOLD INC sold 347,330 shares at $33.83 per share for a total value of $7,497,699.00 on June 24, 2013. Following this transaction, the Director owned 5.6 million shares meaning that the stake was reduced by 6.21% with the 347,330 share sell-off.

The shares most recently traded at $41.31, up $1.02, or 2.53% since the insider transactions. Historical insider transactions for Royal Gold go as follows:

  • 4-Week # shares bought: 2,000
  • 4-Week # shares sold: 142,074
  • 12-Week # shares bought: 2,000
  • 12-Week # shares sold: 142,074
  • 24-Week # shares bought: 3,000
  • 24-Week # shares sold: 152,074

The average volume for Royal Gold has been 980,800 shares per day over the past 30 days. Royal Gold has a market cap of $2.5 billion and is part of the basic materials sector and metals & mining industry. Shares are down 50.48% year to date as of the close of trading on Thursday.

Royal Gold, Inc., together with its subsidiaries, engages in the acquisition and management of precious metals royalties and similar production based interests. The stock currently has a dividend yield of 2.05%. The company has a P/E ratio of 42.1. Currently there are 4 analysts that rate Royal Gold a buy, no analysts rate it a sell, and 2 rate it a hold.

Exclusive Offer: Get the latest Stock Analysis on RGLD - FREE

TheStreet Quant Ratings rates Royal Gold as a hold. The company's strengths can be seen in multiple areas, such as its revenue growth, largely solid financial position with reasonable debt levels by most measures and expanding profit margins. However, as a counter to these strengths, we also find weaknesses including a generally disappointing performance in the stock itself, disappointing return on equity and deteriorating net income. Get the full Royal Gold Ratings Report from TheStreet Quant Ratings now.

STOCKS TO BUY: TheStreet Quant Ratings has identified a handful of stocks that can potentially TRIPLE in the next 12-months. Learn more.

Data for this article provided by Zacks Investment Research

null

More from Markets

Aceto's Search for Deal May Be Slowed by DOJ Subpoena

Aceto's Search for Deal May Be Slowed by DOJ Subpoena

Dow and S&P 500 Finish Higher Amid Strong Corporate Earnings

Dow and S&P 500 Finish Higher Amid Strong Corporate Earnings

Veteran Foreign Affairs Expert Ian Bremmer Reveals How to Price Political Risk

Veteran Foreign Affairs Expert Ian Bremmer Reveals How to Price Political Risk

Investors Shouldn't Be Worried About Trump's Trade Tariffs: Ian Bremmer

Investors Shouldn't Be Worried About Trump's Trade Tariffs: Ian Bremmer

3 Hot Reads From TheStreet's Top Premium Columnists

3 Hot Reads From TheStreet's Top Premium Columnists